Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old
Clinical trial NCT05329961 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05329961
- Sponsor
- Boston Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-26
- Primary completion
- 2028-07-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.